Navigation Links
Gen-Probe Reports Financial Results for the Second Quarter of 2011
Date:7/28/2011

the prior year period, a decrease of 61% that resulted primarily from an expected decrease in funding from Novartis associated with the development of the fully automated PANTHER instrument for the blood screening market.

Royalty and license revenues in the second quarter of 2011 were $1.4 million, compared to $1.8 million in the prior year period.  

GAAP Income Statement DetailsGross margin on product sales was 70.3% in the second quarter of 2011, compared to 66.6% in the prior year period.  This increase resulted mainly from a favorable product sales mix, namely higher sales of APTIMA products and lower sales of instrumentation to Novartis.  

Acquisition-related amortization expenses were $2.7 million in the second quarter of 2011, compared to $2.2 million in the prior year period, an increase of 23% that resulted mainly from the acquisition of GTI in December of 2010.

Research and development (R&D) expenses were $27.7 million in the second quarter of 2011, compared to $27.1 million in the prior year period, an increase of 2% that resulted primarily from the addition of GTI's R&D programs.  

Marketing and sales expenses were $17.5 million in the second quarter of 2011, compared to $15.8 million in the prior year period, an increase of 11% that resulted primarily from the addition of GTI's cost structure, and ongoing European commercial expansion.  

General and administrative (G&A) expenses were $18.7 million in the second quarter of 2011, compared to $15.0 million in the prior year period, an increase of 25% that resulted from the addition of GTI's cost structure, increased legal expenses, and higher stock-based compensation.  

Total other income, net, was $3.8 million in the second quarter of 2011, compared to $6.9 million in the prior year period, a decrease of 45% that resulted primarily from a non-cash gain in the prior year period related to a change in the fair val
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
2. Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
3. Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
4. Gen-Probe to Webcast Presentation at the UBS Global Life Sciences Conference
5. Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
6. Promising Clinical Data on Gen-Probes APTIMA(R) HPV Test Presented at Major European Medical Meeting
7. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2008 Earnings Conference Call
8. Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
9. Gen-Probe Borrows $170 Million Under New Line of Credit
10. Gen-Probe to Webcast Two Upcoming Investor Presentations
11. Gen-Probe Completes Acquisition of Tepnel Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  Biocom, the association representing ... community, recognizes the 9 th Annual National Health ... of IT technologies in improving our health care system. ... is one of the world,s most vibrant hubs for ... mobile health applications to genomic testing to remote patient ...
(Date:9/16/2014)... deicing film for radar domes have now refined the ... , The new work by Rice chemist James ... windshields to skyscrapers free of ice and fog while ... The technology was introduced this month in the American ... , The material is made of graphene nanoribbons, ...
(Date:9/16/2014)... Sept. 16, 2014  Donald Fresne, President and CEO of ... Stephan Vagner , PhD to its Scientific Advisory Committee. ... Toulouse, France , performed research at Embl (European ... at Inserm, the French institute of health and medical research. ... at the Curie Institute, Orsay, France , ...
(Date:9/16/2014)... Sept. 16, 2014   Synthetic Biologics, Inc. ... novel anti-infective biologic and drug programs targeting specific ... the completion of the Company,s Investor Day in ... its irritable bowel syndrome (IBS) program, including its ... In the keynote presentation, Mark ...
Breaking Biology Technology:Biocom Recognizes National Health IT Week 2Nanoribbon film keeps glass ice-free 2New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 3
... ... first private companies providing paternity and other ancestry testing in Germany, ... new German Genetic Diagnosis Act ("Gendiagnostikgesetz"): German legislation has passed several ... as well as paternity testing. The new Genetic Diagnosis Act, which ...
... ... may be asking how the billions poured into science R&D has helped stimulate our economy. ... just ended as their first branded year with new hires, new instruments and more business ... ...
... ON , Jan. 26 /PRNewswire-FirstCall/ - YM BioSciences ... the Company that it may now enroll patients at US ... of its lead product, nimotuzumab. One of the two trials ... for curative treatment and being treated palliatively and the other ...
Cached Biology Technology:bj-diagnostik GmbH: The German Genetic Diagnosis Act will Become Effective 01.02.2010 - What Will Change for Paternity Testing? 2bj-diagnostik GmbH: The German Genetic Diagnosis Act will Become Effective 01.02.2010 - What Will Change for Paternity Testing? 3bj-diagnostik GmbH: The German Genetic Diagnosis Act will Become Effective 01.02.2010 - What Will Change for Paternity Testing? 4US Nanotechnology Instrument Manufacturer Proves the Success of R&D Stimulus 2YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA 2YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA 3YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA 4YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA 5
(Date:9/16/2014)... for the dinosaurs 66 million years ago decimated the ... extent than their deciduous peers, according to a study ... the journal PLOS Biology . , Applying ... fossilized leaves of angiosperms flowering plants excluding ... ecology of a diverse plant community thriving during a ...
(Date:9/16/2014)... the Keystone XL pipeline (KXL) would likely increase oil ... researchers surveyed by the non-profit organization Near Zero. The ... Climate Impact," and includes both supporters and opponents of ... oil sands could lead to significantly higher greenhouse gas ... markets respond. , "This report examines three main ...
(Date:9/16/2014)... Schizophrenia is associated with increased rates and intensity of ... that the relationship between schizophrenia and smoking stems, in ... to self-medicate symptoms and cognitive impairment associated with the ... issue of Biological Psychiatry , sheds light on ... nicotine receptors in the brain was lower in schizophrenia ...
Breaking Biology News(10 mins):Meteorite that doomed dinosaurs remade forests 2Meteorite that doomed dinosaurs remade forests 3Meteorite that doomed dinosaurs remade forests 4Keystone XL would likely raise oil sands production and greenhouse gas emissions 2Smoking and schizophrenia linked by alterations in brain nicotine signals 2
... shows that a "gatekeeper" protein plays an important role in ... C/EBP alpha, is normally abundantly expressed to help protect skin ... The NC State research shows, however, that the protein is ... Moreover, when the protein is inactivated in special lab mice ...
... JOLLA, CAThe seeds sprouting in your spring garden may still be ... finite energy pack contained within each seed. Once those resources are ... a "green" photosynthetic program. Researchers at the Salk Institute for Biological ... In a study published in the May 24, 2011, issue ...
... highly coveted technical capabilities as the observation of ... detection of low concentrations of biochemical agents and ... Researchers with the U.S. Department of Energy (DOE),s ... with researchers at the University of Stuttgart in ...
Cached Biology News:Lack of 'gatekeeper' protein linked to skin cancer 2It's not easy being green 2It's not easy being green 3Sharpening the nanofocus 2Sharpening the nanofocus 3Sharpening the nanofocus 4
... Extract Protein Array Kit is designed for ... The expression of a protein in an ... antibody. When the antibody binds the protein, ... chemiluminescent or fluorescent signal created by directly ...
... Stabilizer is a is a bovine protein-free ... product is an aqueous solution that contains ... buffered saline), pH 6.6 - 7.2. ... methylisothiazolone and 0.02% bromonitrodioxane as a preservative. ...
... mounting medium designed for the preservation ... especially recommended when using tracers containing ... can also be used with conventional ... Rhodamine (TMRITC) and Texas Red. Gel/Mount ...
...
Biology Products: